Skip to main content
Clinical Trials/ISRCTN16085028
ISRCTN16085028Completed未知

Psycho-oncological intervention for partners of patients with haemato-oncological disease

José Carreras Leukemia Foundation0 sites144 target enrollmentStarted: March 20, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
144

Study Overview

Brief Summary

2019 Protocol article in https://doi.org/10.1186/s12885-019-6094-2 (added 10/04/2024)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •1. Patients who are diagnosed with a confirmed haematological neoplasia: incidences up to one year after diagnose or relapse, ICD-10 diagnoses: C81-C96 and D46, which are: Hodgkin’s lymphoma, Non-Hodgkin’s lymphoma, multiple myeloma, myelodysplastic syndrome, acute or chronic leukaemia
  • •2. Patients who have a partner
  • •3. Patients and partners need to be aged between 18 and 70 years
  • •4. Partners must be mentally and physically able to attend the program
  • •5. Treatment modality and phase of illness is negligible for participation
  • •6. Partners will be assigned to one of two study groups, given that PHQ-9 > 9 (depression) and GAD-7 > 9 (anxiety)

Exclusion Criteria

  • •1. Severe psychiatric disorders
  • •2. Profound cognitive and physical impairment
  • •3. An age limitation of 70 years aimed to minimise possible age-related comorbidities or mobility limitations

Investigators

Sponsor
José Carreras Leukemia Foundation

Similar Trials